Picture of Molecular Templates logo

MTEMQ — Molecular Templates News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Molecular Templates Inc jumps 9% on Q4 results

** Drug developer's shares  MTEM.O  up 9% at $2.95 after
market
    ** Company reports Q4 loss of 18 cents/shr vs loss of 57
cents/shr a year earlier; analysts had expected a Q4 loss of 40
cents/shr - Refinitiv data  urn:newsml:reuters.com:*:nASA035OZ
    ** Quarterly revenue rose more than 5x to $18 mln
 urn:newsml:reuters.com:*:nGNX2d0D7X
    ** All 8 brokerages covering MTEM rate the stock "buy" or
higher; median PT $11.50
    ** Up to Monday's close, stock down 31% YTD

 (Reporting by Leroy Leo in Bengaluru)
 ((Leroy.Dsouza@thomsonreuters.com ; Twitter: https://twitter.com/LeroyLeo7))

Recent news on Molecular Templates

See all news